Abiopharma

Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period

Latest About iPod Nano 7th Generation

Shark FlexStyle vs Dyson Airwrap

Latest About Motorola One 5G Ace

Latest About iPhone 13 Mini (2026 Guide)

The Best Handheld Game Consoles For 2026: Ultimate Buying Guide

Tenaya Therapeutics Announces Pricing of Public Offering

Final approval of ANDA #ANDA #213305 for ISOPROTERENOL HYDROCHLORIDE. Decision date: 12/10/2025

Final approval of ANDA #ANDA #217597 for LOTEPREDNOL ETABONATE; TOBRAMYCIN. Decision date: 12/10/2025

New Form 4/A - Nuo Therapeutics, Inc. Filed: 2025-12-11 AccNo: 0001437749-25-037614 Size: 8 KB

Cross Shawn 🟡 adjusted position in 25.0K shares (2 derivative) of Pacira BioSciences, Inc. (PCRX) at $25.14 ($1.4M) Transaction Date: Dec 09, 2025 | Filing ID: 056645

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Venker Eric 🟡 adjusted position in 200.0K shares (1 derivative) of Roivant Sciences Ltd. (ROIV) at $20.85 ($5.7M) Transaction Date: Dec 09, 2025 | Filing ID: 045279

New Form SCHEDULE 13D/A - Opus Genetics, Inc. Filed: 2025-12-11 AccNo: 0001193125-25-316569 Size: 10 KB

MCGUIRE TERRANCE 🟡 adjusted position in 0 shares (1 derivative) of Seer, Inc. (SEER) Transaction Date: Dec 09, 2025 | Filing ID: 000005